BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee MS, Oh JY, Kang CI, Kim ES, Park S, Rhee CK, Jung JY, Jo KW, Heo EY, Park DA, Suh GY, Kiem S. Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia. Infect Chemother 2018;50:160-98. [PMID: 29968985 DOI: 10.3947/ic.2018.50.2.160] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Lim S, Yoo YM, Kim KH. No more tears from surgical site infections in interventional pain management. Korean J Pain 2023;36:11-50. [PMID: 36581597 DOI: 10.3344/kjp.22397] [Reference Citation Analysis]
2 Kim Y, Jeon Y, Kwon KT, Bae S, Hwang S, Chang HH, Kim SW, Lee WK, Yang KH, Shin JH, Shim EK. Beta-Lactam Plus Macrolide for Patients Hospitalized With Community-Acquired Pneumonia: Difference Between Autumn and Spring. J Korean Med Sci 2022;37:e324. [PMID: 36413797 DOI: 10.3346/jkms.2022.37.e324] [Reference Citation Analysis]
3 Er AG, Alonso AAR, Marin-leon I, Sayiner A, Bassetti S, Demirkan K, Lacor P, Lode H, Lesniak W, Tanriover MD, Kalyoncu AF, Merchante N, Unal S. Community-acquired pneumonia – An EFIM guideline critical appraisal adaptation for internists. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.10.009] [Reference Citation Analysis]
4 Mehta Y, Mishra KC, Paliwal Y, Rangappa P, Sinha S, Bhapkar S. Meeting the Unmet Need in the Management of MDR Gram-Positive Infections with Oral Bactericidal Agent Levonadifloxacin. Crit Care Res Pract 2022;2022:2668199. [PMID: 36785544 DOI: 10.1155/2022/2668199] [Reference Citation Analysis]
5 Kim NJ. Multidrug-resistant bacteria: a national challenge requiring urgent addressal. J Korean Med Assoc 2022;65:462-6. [DOI: 10.5124/jkma.2022.65.8.462] [Reference Citation Analysis]
6 Zhang X, Xia R, Gao J, Liu J, Xu D, Li X, Hu X, Willcox M, Moore M, Dai M, Trill J, Fei Y, Liu J. Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Front Pharmacol 2022;13:923395. [DOI: 10.3389/fphar.2022.923395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang G, Wu P, Tang R, Zhang W. Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis. J Antimicrob Chemother 2022:dkac170. [PMID: 35678262 DOI: 10.1093/jac/dkac170] [Reference Citation Analysis]
8 Seo H, Sim YS, Min KH, Lee JH, Kim BK, Oh YM, Ra SW, Kim TH, Hwang YI, Park JW. The Relationship Between Comorbidities and Microbiologic Findings in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2022;17:855-67. [PMID: 35480555 DOI: 10.2147/COPD.S360222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Im H, Ser J, Sim U, Cho H. Promising Expectations for Pneumococcal Vaccination during COVID-19. Vaccines (Basel) 2021;9:1507. [PMID: 34960253 DOI: 10.3390/vaccines9121507] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bendala Estrada AD, Calderón Parra J, Fernández Carracedo E, Muiño Míguez A, Ramos Martínez A, Muñez Rubio E, Rubio-Rivas M, Agudo P, Arnalich Fernández F, Estrada Perez V, Taboada Martínez ML, Crestelo Vieitez A, Pesqueira Fontan PM, Bustamante M, Freire SJ, Oriol-Bermúdez I, Artero A, Olalla Sierra J, Areses Manrique M, Carrasco-Sánchez HFJ, Vento VC, García García GM, Cubero-Morais P, Casas-Rojo JM, Núñez-Cortés JM. Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy. BMC Infect Dis 2021;21:1144. [PMID: 34749645 DOI: 10.1186/s12879-021-06821-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
11 Stalteri Mastrangelo R, Santesso N, Bognanni A, Darzi A, Karam S, Piggott T, Baldeh T, Schünemann F, Ventresca M, Morgano GP, Moja L, Loeb M, Schunemann H. Consideration of antimicrobial resistance and contextual factors in infectious disease guidelines: a systematic survey. BMJ Open 2021;11:e046097. [PMID: 34330853 DOI: 10.1136/bmjopen-2020-046097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Han X, Chen L, Wang Y, Li H, Wang H, Xing X, Zhang C, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu X, Cao B; CAP-China Network. Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward. Infect Drug Resist 2021;14:1845-53. [PMID: 34040398 DOI: 10.2147/IDR.S302852] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Kadri SS. A Reappraisal of Streptococcal Urinary Antigen Testing for Antibiotic Stewardship. Clin Infect Dis 2020;71:1435-7. [PMID: 31587033 DOI: 10.1093/cid/ciz989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Seo H, Cha SI, Shin KM, Lim JK, Lee WK, Park JE, Park S, Choi SH, Lee YH, Yoo SS, Lee SY, Lee J, Kim CH, Park JY. Clinical relevance of emphysema in patients hospitalized with community-acquired pneumonia: Clinical features and prognosis. Clin Respir J 2021;15:826-34. [PMID: 33826807 DOI: 10.1111/crj.13370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Oh H, Heo ST, Kim M, Kim YR, Yoo JR. Antimicrobial Susceptibility Trends of Streptococcus pneumoniae by Age Groups Over Recent 10 Years in a Single Hospital in South Korea. Yonsei Med J 2021;62:306-14. [PMID: 33779084 DOI: 10.3349/ymj.2021.62.4.306] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Oyegoke PI, Olayinka BO, Ehinmidu JO, Tytler BA. Molecular Characterization of Multidrug-resistant Bacteria Isolated From Patients With Pneumonia at Two Hospitals in North-West Nigeria. Int J Epidemiol Res 2021;8:23-30. [DOI: 10.34172/ijer.2021.05] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Sharma R, Sandrock CE, Meehan J, Theriault N. Community-Acquired Bacterial Pneumonia-Changing Epidemiology, Resistance Patterns, and Newer Antibiotics: Spotlight on Delafloxacin. Clin Drug Investig 2020;40:947-60. [PMID: 32889706 DOI: 10.1007/s40261-020-00953-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
18 Kim B, Myung R, Lee MJ, Kim J, Pai H. Trend of Antibiotic Usage for Hospitalized Community-acquired Pneumonia Cases in Korea Based on the 2010-2015 National Health Insurance Data. J Korean Med Sci 2020;35:e390. [PMID: 33289366 DOI: 10.3346/jkms.2020.35.e390] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Heo JY, Seo YB, Jeong HW, Choi MJ, Min KH, Choi WS, Lee J, Noh JY, Cheong HJ, Kim WJ, Song JY. Epidemiology of community-acquired pneumonia in the era of extended serotype-covering multivalent pneumococcal conjugate vaccines. Vaccine 2020;38:7747-55. [PMID: 33164798 DOI: 10.1016/j.vaccine.2020.10.046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
20 Triana AJ, Molinares JL, Del Rio‐pertuz G, Meza JL, Ariza‐bolívar O, Robledo‐solano A, Acosta‐reyes J. Clinical practice guidelines for the management of community‐acquired pneumonia: A critical appraisal using the AGREE II instrument. Int J Clin Pract 2020;74. [DOI: 10.1111/ijcp.13478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
21 Bontsevich RA, Gavrilova AA, Vovk YR, Adonina AV, Goncharova NY, Prozorova GG, Kompaniets OG, Barysheva VO, Ketova GG, Bochanova EN, Mironenko EV, Shagiyeva TM, Kirichenko AA, Krotkova IF, Shabanov EA, Tilekeyeva UM, Luchinina EV, Galkina IP, Maksimov ML, Nevzorova VA. The assessment of physicians' and senior medical students’ knowledge in the field of community-acquired pneumonia: preliminary results of the KNOCAP-II project (2017-2019). Medicni perspektivi (Medical perspectives) 2020;25:59-65. [DOI: 10.26641/2307-0404.2020.1.200402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Bontsevich RA, Gavrilova AA, Adonina AV, Vovk YR, Goncharova NY, Batisheva GA, Cherenkova OV, Myronenko OV, Luchinina EV, Barysheva VO, Ketova GG, Bochanova EN, Tilekeeva UM, Dauletbekov ND. Pharmacotherapy and other aspects of senior medical students’ knowledge in community-acquired pneumonia: the final results of the KNOCAP II project. RRP 2020;6:93-99. [DOI: 10.3897/rrpharmacology.6.49977] [Reference Citation Analysis]
23 Froes F, Pereira JG, Póvoa P. Outpatient management of community-acquired pneumonia. Current Opinion in Pulmonary Medicine 2019;25:249-56. [DOI: 10.1097/mcp.0000000000000558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Choi S, Lee D. Principles of selecting appropriate antimicrobial agents. J Korean Med Assoc 2019;62:335. [DOI: 10.5124/jkma.2019.62.6.335] [Reference Citation Analysis]
25 Bontsevich R, Filinichenko T, Gavrilova A, Goncharova N, Kompaniets O, Luchinina E, Shagieva T, Ni O, Ketova G, Eliseeva E, Osipova O, Shchurovskaya K, Leonov A, Milutina E, Barysheva V, Ofori D. Assessment of physicians’ and senior medical students’ knowledge in treatment of patients with community-acquired pneumonia: Current results of the KNOCAP project. RRP 2018;4:27-36. [DOI: 10.3897/rrpharmacology.4.29454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
26 Heo JY, Song JY. Disease Burden and Etiologic Distribution of Community-Acquired Pneumonia in Adults: Evolving Epidemiology in the Era of Pneumococcal Conjugate Vaccines. Infect Chemother 2018;50:287-300. [PMID: 30600652 DOI: 10.3947/ic.2018.50.4.287] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]